118 related articles for article (PubMed ID: 2842550)
1. Resistance to RadLV-induced leukemia: non-participation of splenic natural killer cells.
St-Pierre Y; Hugo P; Lemieux S; Lussier G; Potworowski EF
Leukemia; 1988 Aug; 2(8):551-3. PubMed ID: 2842550
[TBL] [Abstract][Full Text] [Related]
2. H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.
Lonai P; Katz E; Peled A; Haran-Ghera N
Immunogenetics; 1981 Mar; 12(5-6):423-32. PubMed ID: 6260638
[TBL] [Abstract][Full Text] [Related]
3. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes.
Meruelo D
J Exp Med; 1979 Apr; 149(4):898-909. PubMed ID: 219130
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of role of natural killer cells in radiation-induced leukemogenesis in mice.
Gorelik E; Rosen B; Copeland D; Weatherly B; Herberman RB
J Natl Cancer Inst; 1984 Jun; 72(6):1397-403. PubMed ID: 6374239
[TBL] [Abstract][Full Text] [Related]
5. Ly 11.2: a cell surface antigen that may identify murine lymphocytes susceptible to transformation by oncogenic agents.
Meruelo D; Paolino A; Flieger N; Offer M; Dworkin J
Fed Proc; 1981 Oct; 40(12):2717-20. PubMed ID: 6269904
[No Abstract] [Full Text] [Related]
6. Down-regulation of natural killer cell activity in MoLV leukemogenesis: evidence for tumor-cell-mediated suppression.
Ofir R; Weinstein Y; Rager-Zisman B
Nat Immun Cell Growth Regul; 1988; 7(2):77-86. PubMed ID: 2842667
[TBL] [Abstract][Full Text] [Related]
7. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.
Haran-Ghera N; Ben-Yaakov M; Peled A
J Immunol; 1977 Feb; 118(2):600-6. PubMed ID: 320261
[TBL] [Abstract][Full Text] [Related]
8. Altered natural killer cell biology in C57BL/6 mice after leukemogenic split-dose irradiation.
Parkinson DR; Brightman RP; Waksal SD
J Immunol; 1981 Apr; 126(4):1460-4. PubMed ID: 7009740
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow phenotype determines genetic resistance to RadLV-induced leukemia in radiation chimeric mice.
St-Pierre Y; Lussier G; Potworowski EF
Leuk Res; 1987; 11(3):307-9. PubMed ID: 3031387
[TBL] [Abstract][Full Text] [Related]
10. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay determination of two main cross-reacting viral antigens during radiation and Rauscher induced leukemias.
Sassen A; Vander Plaetse F; Janowski M; Maisin JR
Biomedicine; 1979 Jul; 30(3):147-55. PubMed ID: 486687
[TBL] [Abstract][Full Text] [Related]
12. Natural killer (NK) cells and interferon in Friend-virus-infected susceptible and resistant mice.
Hertenstein B; Kreja L; Seidel HJ
Exp Hematol; 1984 Aug; 12(7):603-9. PubMed ID: 6204881
[TBL] [Abstract][Full Text] [Related]
13. [Experimental studies on a role of NK activity in murine myeloid leukemogenesis].
Shiomi Z
Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):839-45. PubMed ID: 3206981
[No Abstract] [Full Text] [Related]
14. Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2.
Christopher FL; Dussault I; Miller SC
Immunobiology; 1991 Dec; 184(1):37-52. PubMed ID: 1800310
[TBL] [Abstract][Full Text] [Related]
15. In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.
Yefenof E; Meidav A; Kedar E
J Exp Med; 1980 Dec; 152(6):1473-83. PubMed ID: 6256461
[TBL] [Abstract][Full Text] [Related]
16. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM
Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
[TBL] [Abstract][Full Text] [Related]
17. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
Afifi MS; Bennett M; Kumar V
Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
[TBL] [Abstract][Full Text] [Related]
18. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. II. Analysis of the immune response.
Haran-Ghera N; Rubio N
J Immunol; 1977 Feb; 118(2):607-11. PubMed ID: 839072
[TBL] [Abstract][Full Text] [Related]
19. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
Xun CQ; Thompson JS; Jennings CD; Brown SA
Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
[TBL] [Abstract][Full Text] [Related]
20. Target cells and thymus microenvironment in the pathogenesis of thymic lymphomas in C57BL/Ka mice.
Boniver J; Houben-Defresne MP; Goffinet G; Lenaerts P; Betz EH
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):65-9. PubMed ID: 2981792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]